BIOPOL CHEMICALS IPO
A Glimpse into the Offering
| IPO Period | 06th – 10th Feb 2026 |
|---|---|
| Listing on | 13 Feb 2026 |
| Price Band | ₹102 – ₹108 |
| Lot Size & Minimum Investment | 1200 shares, amounting to ₹129600 |
| Total Issue Size | ₹31.26 crore |
Key Dates for Investors
- Opening Date: 06 Feb 2026
- Closing Date: 10 Feb 2026
- UPI Payment Deadline: 10 Feb 2026 (5 PM)
- Allotment Announcement: 11 Feb 2026
- Refund Processing: 12 Feb 2026
- Demat Credit: 12 Feb 2026
- Stock Market Listing: 13 Feb 2026
- Mandate Validity End: 25 Feb 2026
- Anchor Investor Lock-in Release (50%): 13 Mar 2026
- Anchor Investor Lock-in Release (Remaining): 12 May 2026
*Dates may be revised as per official updates.
Deep Dive into BIOPOL CHEMICALS
Founded in April 2023 as a private limited entity, BIOPOL CHEMICALS Limited swiftly transitioned into a public limited company in May 2024. Headquartered in Ahmedabad, Gujarat, the company has strategically absorbed the business of United Chemical Company, consolidating operations to foster robust growth and market expansion. At its helm are visionary promoters, Mr. Santanu Sarkar and Mr. Vedant Sarkar, whose industry acumen guides the company’s trajectory.
BIOPOL CHEMICALS operates dynamically within the speciality chemicals segment, distinguishing itself through its comprehensive involvement in manufacturing, trading, and distribution. Its expansive product portfolio is a testament to its diversified capabilities, encompassing silicones, emulsifiers, biochemicals, and polyelectrolytes. These critical chemical solutions find widespread application across various industrial sectors, including textiles, home care, agriculture, and general industrial chemicals.
The company primarily adheres to a Business-to-Business (B2B) model, providing tailored, application-driven solutions to a broad spectrum of institutional customers. This approach is reinforced by a robust sales strategy that combines direct customer engagement with an extensive distributor network, reaching clients across domestic markets and select international geographies. Beyond product offerings, BIOPOL CHEMICALS enhances customer value by providing expert technical consultancy, ensuring optimal application and performance of its chemical solutions. This blend of quality products, technical support, and strong customer relationships underpins its competitive positioning in the speciality chemicals sector.
Unpacking the Financials and Issue Details
| Total Funds Raised | ₹31.26 crore |
|---|---|
| Fresh Issue Component | ₹31.26 crore |
| Offer for Sale Component | ₹0 crore |
The BIOPOL CHEMICALS IPO is structured entirely as a fresh issue, aiming to raise ₹31.26 crore. This means that all proceeds from the offering will directly flow into the company’s coffers, fortifying its financial base and enabling it to pursue its strategic growth initiatives. The absence of an Offer for Sale (OFS) component indicates that existing shareholders are not selling their stakes, underscoring the company’s focus on capital infusion for future development rather than providing an exit for early investors.
While specific detailed financial figures for revenue growth and profitability are not publicly disseminated in this IPO data, the company highlights “consistent revenue growth and profitability over recent financial periods” as a key strength. This suggests a healthy financial trajectory that underpins its expansion plans and appeals to potential investors seeking fundamentally sound opportunities.
Strategic Utilization of Capital
The funds garnered from the fresh issue are earmarked for several strategic purposes, designed to enhance operational capabilities, strengthen the balance sheet, and support overall corporate objectives. The detailed breakdown of capital allocation is as follows:
| Objective | Amount (INR Crores) | Allocation % |
|---|---|---|
| Acquisition of industrial land | 12.26 | 39.23% |
| Repayment/prepayment of borrowings | 11.1 | 35.51% |
| General corporate purposes | 7.9 | 25.26% |
A significant portion of the capital, nearly 40%, is allocated towards the acquisition of industrial land. This investment is crucial for expanding the company’s manufacturing footprint, enhancing production capacities, and potentially accommodating future growth initiatives. Another substantial allocation, over 35%, is directed towards the repayment or prepayment of existing borrowings. This move is expected to deleverage the company, reduce interest expenses, and improve its financial health, thereby strengthening its balance sheet. The remaining funds are designated for general corporate purposes, providing the company with the necessary flexibility to meet ongoing operational expenses, strategic investments, and unforeseen contingencies.
Distinctive Strengths of BIOPOL CHEMICALS
- Diverse Speciality Chemicals Portfolio: BIOPOL CHEMICALS boasts a broad range of speciality chemicals, including silicones, biochemicals, emulsifiers, and polyelectrolytes. This diversification not only reduces dependence on a single product category but also allows the company to cater to a wider array of industrial applications and customer needs.
- Robust Presence in Textile Chemicals: The company has cultivated a strong foothold in the textile chemicals segment, supported by well-established relationships with institutional customers. This specialized focus within a key industry provides a stable revenue stream and showcases its expertise in catering to specific sector demands.
- Experienced Promoter Leadership: As a promoter-led organization, BIOPOL CHEMICALS benefits from the deep domain experience and continuous operational guidance of its founders. This ensures strategic continuity, fosters strong leadership, and leverages invaluable industry insights gained from a legacy business.
- Effective B2B Business Model: The company’s B2B approach, complemented by technical consultancy support, is characterized by repeat demand from its institutional clientele. This model facilitates stable customer relationships, enables customized solutions, and builds a sustainable revenue pipeline.
- Consistent Financial Performance: BIOPOL CHEMICALS has demonstrated consistent revenue growth and profitability over recent financial periods. This positive financial trend underscores the effectiveness of its business strategies, operational efficiencies, and market acceptance of its products, reflecting a healthy and growing enterprise.
Considerations for Potential Investors
- Reliance on the Textile Industry: A significant portion of BIOPOL CHEMICALS’ revenue is linked to the textile industry. This exposes the company to the inherent cyclicality and demand fluctuations of the sector, which could impact its financial performance during downturns.
- Geographical Revenue Concentration: The company’s revenue streams exhibit a geographical concentration, primarily in regions like West Bengal, Gujarat, and Bangladesh. This reliance on specific markets could make the company vulnerable to regional economic downturns, regulatory changes, or increased competition in these areas.
- Dependency on Key Raw Material Suppliers: BIOPOL CHEMICALS relies on a limited number of suppliers for its essential raw materials. Any disruption in the supply chain, adverse price movements, or quality issues from these key suppliers could impact production costs, operational efficiency, and profitability.
- Lack of Prior Listed Market History: This IPO marks BIOPOL CHEMICALS’ first public issue, meaning there is no prior listed market history for its equity shares. Investors will not have historical trading data to analyze, which could introduce a higher degree of uncertainty compared to investing in companies with established market presence.
- Regulatory and Environmental Compliance Risks: Operating in the chemical manufacturing sector inherently involves navigating complex regulatory and environmental compliance frameworks. Non-compliance, new stringent regulations, or environmental incidents could lead to significant penalties, operational disruptions, and reputational damage.
Latest Subscription Data
Subscription statistics based on the latest available information:
| Investor Category | Shares Reserved (Lakhs) | Shares Applied (Lakhs) | Subscription (Times) |
|---|---|---|---|
| Qualified Institutional Buyers (QIB) | Data Not Available | Data Not Available | Data Not Available |
| Non-Institutional Investors (NII) | Data Not Available | Data Not Available | Data Not Available |
| Retail Individual Investors (RII) | Data Not Available | Data Not Available | Data Not Available |
| Total | Data Not Available | Data Not Available | Data Not Available |
*Subscription data and GMP figures are unofficial and may vary; exchange data is more reliable. Investors are advised to refer to official exchange platforms for real-time and confirmed figures during the subscription period.
How to Apply
Investors keen on participating in the BIOPOL CHEMICALS IPO can do so through the official Dhan Kirti IPO platform. Ensure your application is submitted well before the subscription window closes on 10th February 2026.
